2022
DOI: 10.1016/j.clinmicnews.2022.10.001
|View full text |Cite
|
Sign up to set email alerts
|

It's Bordetella, It's Alcaligenes… No, It's Achromobacter! Identification, Antimicrobial Resistance, and Clinical Significance of an Understudied Gram-Negative Rod

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 16 publications
0
2
0
Order By: Relevance
“…However, following the ESLL intervention, the abundance of Achromobacter was significantly reduced. It has been reported that Achromobacter is an opportunistic pathogen [ 39 ], and its proliferation can induce damage to the intestinal barrier [ 40 ], leading to the entry of LPS from the gut into the bloodstream, which can trigger systemic inflammation [ 41 ]. This is consistent with the results of this study, which showed significant positive correlations between serum LPS, TNF-α, IL-6, and IL-1β levels and the abundance of Achromobacter .…”
Section: Discussionmentioning
confidence: 99%
“…However, following the ESLL intervention, the abundance of Achromobacter was significantly reduced. It has been reported that Achromobacter is an opportunistic pathogen [ 39 ], and its proliferation can induce damage to the intestinal barrier [ 40 ], leading to the entry of LPS from the gut into the bloodstream, which can trigger systemic inflammation [ 41 ]. This is consistent with the results of this study, which showed significant positive correlations between serum LPS, TNF-α, IL-6, and IL-1β levels and the abundance of Achromobacter .…”
Section: Discussionmentioning
confidence: 99%
“…During diagnostic culturing and identification, various Achromobacter species are frequently identified as A. xylosoxidans due to technical limitations ( 20 ), and by some older methods such as morphological and biochemical phenotyping even as P. aeruginosa or Burkholderia cepacia complex ( 21 ). Whether or not it is clinically relevant to better discriminate between different Achromobacter species is not fully understood, as the virulence of both A. xylosoxidans and other Achromobacter species is poorly characterized ( 22 ).…”
Section: Introductionmentioning
confidence: 99%